A

ADC Therapeutics

Lausanne, Switzerland Founded 2011 NYSE: ADCT
Nanomedicine Cancer Nanotherapy Drug Delivery Protein Nanoparticles Nano-Bio

About

Antibody drug conjugates for hematological malignancies

Company Details

Type
public
Employees
300+
Funding
Public

Key Products

  • Zynlonta
  • PBD-based ADCs
Visit Website

Related Companies

N

Nanosphere (Luminex)

Northbrook, United States

N

NanoString Technologies

Seattle, United States

N

Nanobiotix

Paris, France

A

Arrowhead Research

Pasadena, United States